Clinical landscape of oncolytic virus research in 2020

by Howard L Kaufman, Rizwan Haq, Nicholas Macedo, David M Miller
Published 2020-07-01

Clindamycin 1% Nano-emulsion Gel Formulation for the Treatment of Acne Vulgaris: Results of a Randomized, Active Controlled, Multicentre, Phase IV Clinical Trial

by Bhavik Bhavsar, Bimal Choksi, Jayesh Sanmukhani, Alka Dogra, Rizwan Haq, Sudhanshu Mehta, Santanu Mukherjee, V Subramanian, Shafiq Sheikh, Ravindra Mittal
Published 2014-08-01

Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition

by Girish S. Naik, Sushrut S. Waikar, Alistair E. W. Johnson, Elizabeth I. Buchbinder, Rizwan Haq, F. Stephen Hodi, Jonathan D. Schoenfeld, Patrick A. Ott
Published 2019-03-01

YY1 regulates melanocyte development and function by cooperating with MITF.

by Juying Li, Jun S Song, Robert J A Bell, Thanh-Nga T Tran, Rizwan Haq, Huifei Liu, Kevin T Love, Robert Langer, Daniel G Anderson, Lionel Larue, David E Fisher
Published 2012-01-01

Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial

by Mariano Severgnini, Rizwan Haq, Anita Giobbie-Hurder, Scott J Rodig, Patrick A Ott, Evisa Gjini, Ryan J Sullivan, Donald P Lawrence, Matthew Nazzaro, Kathleen L Pfaff, Jacquelyn O Wolff, Elizabeth I Buchbinder
Published 2021-11-01

317 B7-H3-targeted CAR T cell with an inducible caspase 9 suicide gene effectively eradicates uveal melanoma liver metastases

by Yi Sun, Cristina R Ferrone, Rizwan Haq, Soldano Ferrone, Genevieve M Boland, Sandra Ryeom, Russell W Jenkins, Giulia Cattaneo, Marco Ventin, Shahrzad Arya, Jingyu Jia, Luke Maggs, Xinhui Wang, Bruce R Ksander
Published 2023-11-01

Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade

by Elizabeth I. Buchbinder, Jason L. Weirather, Michael Manos, Brian J. Quattrochi, Lynette M. Sholl, Ryan C. Brennick, Peter Bowling, Nancy Bailey, Lisa Magarace, Patrick A. Ott, Rizwan Haq, Benjamin Izar, Anita Giobbie‐Hurder, F. Stephen Hodi
Published 2021-04-01

Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapies

by Joan Montero, Cécile Gstalder, Daniel J. Kim, Dorota Sadowicz, Wayne Miles, Michael Manos, Justin R. Cidado, J. Paul Secrist, Adriana E. Tron, Keith Flaherty, F. Stephen Hodi, Charles H. Yoon, Anthony Letai, David E. Fisher, Rizwan Haq
Published 2019-11-01

Clinical profiling of BCL-2 family members in the setting of BRAF inhibition offers a rationale for targeting de novo resistance using BH3 mimetics.

by Dennie T Frederick, Roberto A Salas Fragomeni, Aislyn Schalck, Isabel Ferreiro-Neira, Taylor Hoff, Zachary A Cooper, Rizwan Haq, David J Panka, Lawrence N Kwong, Michael A Davies, James C Cusack, Keith T Flaherty, David E Fisher, James W Mier, Jennifer A Wargo, Ryan J Sullivan
Published 2014-01-01

Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases

by Alexander Z. Wei, Matan Uriel, Agata Porcu, Michael P. Manos, Ann C. Mercurio, Michael M. Caplan, Liam Hulse, Rino S. Seedor, Marta Holovatska, Jasmine Francis, Shaheer A. Khan, Diana E. McDonnell, Dmitry Bogomolny, Takami Sato, Brian P. Marr, Rizwan Haq, Marlana Orloff, Alexander Shoushtari, Richard D. Carvajal
Published 2022-09-01

YY1 Regulates Melanocyte Development and Function by Cooperating with MITF

by Li, Juying, Bell, Robert J. A., Liu, Huifei, Love, Kevin T., Larue, Lionel, Song, Jun S., Tran, Thanh-Nga Trinh, Haq, Rizwan, Langer, Robert S., Anderson, Daniel Griffith, Fisher, David Erich
Published 2013